
 


| Target Audience: |
| This activity is intended for the neurologist. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
| AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
| Faculty |
Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of
Clinical Neurology
Weill
Medical College
Chief of
Division of Stroke and Critical Care Neurology
NewYork
Presbyterian Hospital
Executive Editor
Leslie Coplin
Managing Editor
Neill Kimball
Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience
Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular
Disorders
Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology
and Neuroscience;
Specialty area, Movement Disorders
John J. Caronna, MD
Professor of Clinical Neurology;
Specialty area, Stroke and General Neurology
Authors
Michael Lin, MD, PhD
Associate Professor of Neurology and Neurosciences
Weill Cornell Medical College
Douglas Labar, MD, PhD
Professor of Neurology and Neruoscience
Weill Cornell Medical College
|
| Subjects: |
- Primary Progressive Apraxia of Speech: A Distinct Disorder
- New Therapies for Tinnitus
- Predicting Response to IVIG or Plasmapheresis in Myasthenia Gravis
- An Advance in the Search for Parkinson's Disease Biomarkers
- Outcome of Shunting for Idiopathic 'Normal Pressure Hydrocephalus'
- Stroke Alert: A Review of Current Clinical Stroke Literature
|
| Objectives: |
- Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimers disease, transient ischemic attack, and coma
- Discuss the pathogenesis and treatment of pain
- Present basic science lessons in brain function
- Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
- Discuss nonclinical issues of importance to neurologists, such as the right to die and the physicians legal obligation to patients with terminal illness
|
| Financial Disclosure: |
Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors Michael Rubin, MD, FRCP(C), author Michael Lin, MD, PhD, author Douglas Labar, MD, PhD, author John J. Caronna, MD, peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.
Copyright 2012 AHC Media LLC. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|